Investment analysts at StockNews.com initiated coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a report released on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Piper Sandler reaffirmed an “overweight” rating and issued a $5.00 price […]